Asia-Pacific Autoimmune Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Market Overview

The treatment of autoimmune diseases requires diagnosis of the disease at the onset of disease or later. This involves clinical laboratories checking for symptoms and providing the information to physician for better treatment of the disease. All the diagnostic laboratories do not have proper equipment for carrying out immunoassays. In that case, patient will face trouble in getting the tests done and then handing over the result to the physician. To overcome these problems, recently physicians and clinical laboratories started collaborating. Since, a physician knows where proper immunoassays and immunodiagnostics can be carried out, physician collaborates with that laboratory and suggests patient to get their tests done from there and the results will directly be sent to the physician. Furthermore, with increasing usage of Electronic Medical Records (EMR), labs have access to real-time test data and metrics extracted from the Laboratory Information System (LIS) and physicians too have access to these records, which increases efficiency in diagnosis, thus boosting autoimmune diagnostics market.

Scope of the report

Autoimmunity involves the loss of normal immune homeostasis, as the organism produces an abnormal response to its own tissue. Autoimmune diseases generally involve the presence of self-reactive T cells, autoantibodies, and inflammation. 

Report scope can be customized per your requirements. Click here.

Key Market Trends

Immunologic Assays Segment is Expected to Show Better Growth During the Forecast Years

Based on Diagnosis, the market is segmented into Regular Laboratory Tests, Inflammatory Markers, Immunologic Assays, Antibody Tests and Other Tests. The factors responsible for the growth of the market include cost-effectiveness, growth in the biotechnology and pharmaceutical sectors, and high sensitivity and specificity of immunoassays. When compared to conventional tests, immunologic assays have been proven to provide highly accurate results, even with very small samples. 

Immunologic reactions are highly specific, as they can take place only in the presence of proper immunologic agents. This high specificity indicates high accuracy in results, enabling high sensitivity in the detection of diseases. It helps in easy detection and eliminates the need for secondary verification, which ultimately saves costs. Hence, owing to these factors, the segment is expected to show better growth in the forecast period.

To understand key trends, Download Sample Report